■ 연제 : Mechanisms of SPP1/αvβ3 axis mediated enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategy

■ 연사 : Xiacong Pang 교수

■ 소속 : Peking University First Hospital

■ 일시 : 2025년 10월 02일(목) 17:00 : 비대면 진행

■ Zoom 회의 참가 (16:30부터 입장가능)

https://ewha.zoom.us/j/87977623649?pwd=m5EzuHDwowNxwKzxsuatLnWU8btSgh.1

 Xiaocong Pang, Deputy Director of the Department of Pharmacy, Peking University First Hospital. She currently serves as a member of the Early Career Researchers Subcommittee of the International Union of Basic and Clinical Pharmacology (IUPHAR), a council member of the Beijing Pharmacological Society, a member of the Oncologic Drug Committee of the Beijing Pharmaceutical Association. As a recipient of BJNSF for Distinguished Young Scholars, she also leds more than 10 national, provincial, and institutional research projects, supported by the National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, etc. She is primarily engaged in the development and evaluation of innovative drugs driven by clinical needs. As the corresponding author or first author, she has published over 20 SCI papers in leading journals, including Signal Transduction and Targeted Therapy, JAMA Oncology, Advanced Science, etc. She holds 4 authorized Chinese patents, 1 international PCT patent, 3 software copyrights.